Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DGKA | P23743 | 1/20 | 0.47 |
| ▸ | PTGS1 | P23219 | 3/20 | 0.46 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.46 |
| ▸ | MGLL | Q99685 | 2/20 | 0.46 |
| ▸ | FAAH | O00519 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | PAM | P19021 | 2/20 | 0.43 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.43 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.43 |
| ▸ | POLL | Q9UGP5 | 1/20 | 0.43 |
| ▸ | POLH | Q9Y253 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 2/20 | 0.42 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.42 |
| ▸ | NLRP3 | Q96P20 | 1/20 | 0.42 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CES2 | O00748 | 3/20 | 0.41 |
| ▸ | CES1 | P23141 | 3/20 | 0.41 |
| ▸ | DNM1 | Q05193 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19067107 | 1.00 | DGKA (0.47) | DGKAPTGS1PTGS2MGLLFAAH | |
| SCHEMBL2223792 | 1.00 | DGKA (0.47) | DGKAPTGS1PTGS2MGLLFAAH | |
| SCHEMBL4812972 | 1.00 | DGKA (0.47) | DGKAPTGS1PTGS2MGLLFAAH | |
| SCHEMBL209163 | 0.98 | DGKA (0.44) | DGKAPTGS1PTGS2MGLLFAAH | |
| SCHEMBL28168374 | 0.93 | ALDH1A1 (0.42) | DGKAPTGS1PTGS2MGLLFAAH | |
| SCHEMBL13356960 | 0.91 | PTGS1 (0.44) | DGKAPTGS1PTGS2MGLLFAAH | |
| SCHEMBL714989 | 0.85 | ALDH1A1 (0.44) | PTGS1PTGS2MGLLFAAHLMNA | |
| SCHEMBL28390950 | 0.85 | ALDH1A1 (0.38) | PTGS1PTGS2MGLLFAAHLMNA | |
| SCHEMBL26256263 | 0.84 | GAA (0.49) | FAAHKMT2A | |
| SCHEMBL31121828 | 0.82 | PTGS1 (0.53) | PTGS1PTGS2LMNAMAPTTSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11524969-B2 | Pyrrolobenzodiazepines and conjugates thereof as antitumour agents | MEDIMMUNE LIMITED (GB) | 2022-12-13 | — | — | US | disclosed |
| US-20210079023-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF AS ANTITUMOUR AGENTS | MEDIMMUNE LIMITED (GB) | 2021-03-18 | — | — | US | disclosed |
| WO-2017100714-A1 | CELL PENETRATING CYANINE-COUPLED ANTIBODIES | CITY OF HOPE (US) | 2017-06-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11524969-B2 | Pyrrolobenzodiazepines and conjugates thereof as antitumour agents | PBRM1, HDAC6, NPM1 | DGKA 3941/4885PTGS1 3824/4885PTGS2 3582/4885 |
| US-20210079023-A1 | PYRROLOBENZODIAZEPINES AND CONJUGATES THEREOF AS ANTITUMOUR AGENTS | PBRM1, HDAC6, NPM1 | DGKA 3941/4885PTGS1 3824/4885PTGS2 3582/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.